OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer
Sarah A. Best, Patrick M. Gubser, Shalini Sethumadhavan, et al.
Cell Metabolism (2022) Vol. 34, Iss. 6, pp. 874-887.e6
Open Access | Times Cited: 97

Showing 51-75 of 97 citing articles:

Resistance in Lung Cancer Immunotherapy and How to Overcome It: Insights from the Genetics Perspective and Combination Therapies Approach
Paweł Zieliński, Maria Stępień, Hanna Chowaniec, et al.
Cells (2025) Vol. 14, Iss. 8, pp. 587-587
Open Access

Aberrant metabolic processes promote the immunosuppressive microenvironment in multiple myeloma
Junqiang Lv, Hao Sun, Lixin Gong, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16

Tumor-intrinsic metabolic reprogramming and how it drives resistance to anti-PD-1/PD-L1 treatment
Kyra Laubach, Tolga Turan, Rebecca Mathew, et al.
Cancer Drug Resistance (2023) Vol. 6, Iss. 3, pp. 611-41
Open Access | Times Cited: 10

Metabolism in stem cell driven leukaemia: parallels between haematopoiesis and immunity
Kevin M. Rattigan, Martha M. Zarou, G. Vignir Helgason
Blood (2023)
Open Access | Times Cited: 9

Advanced Biomaterials with Intrinsic Immunomodulation Effects for Cancer Immunotherapy
Weizhi Chen, Cheng Li, Xiqun Jiang
Small Methods (2023) Vol. 7, Iss. 5
Closed Access | Times Cited: 9

Glutamine Deficiency Promotes Immune and Endothelial Cell Dysfunction in COVID-19
William Durante
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7593-7593
Open Access | Times Cited: 9

Metabolic rewiring and communication in cancer immunity
Nicole M. Chapman, Hongbo Chi
Cell chemical biology (2024) Vol. 31, Iss. 5, pp. 862-883
Open Access | Times Cited: 3

IL-1α facilitates GSH synthesis to counteract oxidative stress in oral squamous cell carcinoma under glucose-deprivation
Yikang Ji, Zhen Zhang, Xinran Zhao, et al.
Cancer Letters (2024) Vol. 589, pp. 216833-216833
Closed Access | Times Cited: 3

Immunonutrition, Metabolism, and Programmed Cell Death in Lung Cancer: Translating Bench to Bedside
Palma Fedele, Anna Santoro, Francesca Pini, et al.
Biology (2024) Vol. 13, Iss. 6, pp. 409-409
Open Access | Times Cited: 3

The tRNA Gm18 methyltransferase TARBP1 promotes hepatocellular carcinoma progression via metabolic reprogramming of glutamine
Xiaoyan Shi, Yangyi Zhang, Yuci Wang, et al.
Cell Death and Differentiation (2024) Vol. 31, Iss. 9, pp. 1219-1234
Closed Access | Times Cited: 3

Reprogramming T-Cell Metabolism for Better Anti-Tumor Immunity
Yu P, Chunyi Shen, Bo Huang, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 3103-3103
Open Access | Times Cited: 15

Cancer Cell Metabolism Reprogramming and Its Potential Implications on Therapy in Squamous Cell Carcinoma of the Head and Neck: A Review
Francesco Perri, Giuseppina Della Vittoria Scarpati, Monica Pontone, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3560-3560
Open Access | Times Cited: 13

Effects of metabolic cancer therapy on tumor microenvironment
Petra Hyroššová, Mirko Milošević, Josef Škoda, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13

Metabolic Challenges in Anticancer CD8 T Cell Functions
Andrea M. Amitrano, Minsoo Kim
Immune Network (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7

Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer
Nerea Otegui, Maeva Houry, Imanol Arozarena, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3076-3076
Open Access | Times Cited: 7

Causal effects of circulating glutamine on colitis, IBD, and digestive system cancers: a Mendelian randomisation study
Yang Xie, Yonghui Wu, Qing Tao, et al.
Journal of Cancer (2024) Vol. 15, Iss. 12, pp. 3738-3749
Open Access | Times Cited: 2

myCAF-derived exosomal PWAR6 accelerates CRC liver metastasis via altering glutamine availability and NK cell function in the tumor microenvironment
Hongsheng Fang, Weixing Dai, Ruiqi Gu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2

Alone and Together: Current Approaches to Targeting Glutaminase Enzymes As Part of Anti-Cancer Therapies
Thuy‐Tien T. Nguyen, William P. Katt, Richard A. Cerione
Future Drug Discovery (2022) Vol. 4, Iss. 4
Open Access | Times Cited: 12

Therapeutic Targeting of Glutaminolysis as a Novel Strategy to Combat Cancer Stem Cells
Ting‐Wan Kao, Yao-Chen Chuang, Hsin‐Lun Lee, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15296-15296
Open Access | Times Cited: 11

The metabolic cross-talk between cancer and T cells
Silvia Cardenas-De Miguel, Giulia Lucianer, Ilaria Elia
Trends in Biochemical Sciences (2023) Vol. 48, Iss. 7, pp. 597-609
Open Access | Times Cited: 6

Metabolic Alterations in Canine Mammary Tumors
Guilherme Henrique Tamarindo, Adriana Alonso Novais, Luiz Gustavo de Almeida Chuffa, et al.
Animals (2023) Vol. 13, Iss. 17, pp. 2757-2757
Open Access | Times Cited: 6

Posttranslational regulation of liver kinase B1 in human cancer
Lanlin Hu, Mingxin Liu, Bo Tang, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 4, pp. 104570-104570
Open Access | Times Cited: 5

Immunometabolism of dendritic cells in health and disease
Chuansheng Guo, Hongbo Chi
Advances in immunology (2023), pp. 83-116
Closed Access | Times Cited: 5

Scroll to top